Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Zika virus crosses an in vitro human blood brain barrier model.

Alimonti JB, Ribecco-Lutkiewicz M, Sodja C, Jezierski A, Stanimirovic DB, Liu Q, Haqqani AS, Conlan W, Bani-Yaghoub M.

Fluids Barriers CNS. 2018 May 15;15(1):15. doi: 10.1186/s12987-018-0100-y.

2.

Immune Response to Marburg Virus Angola Infection in Nonhuman Primates.

Fernando L, Qiu X, Melito PL, Williams KJ, Feldmann F, Feldmann H, Jones SM, Alimonti JB.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S234-41. doi: 10.1093/infdis/jiv095. Epub 2015 May 9.

PMID:
25957966
3.

A Recombinant Vesicular Stomatitis Virus Ebola Vaccine.

Regules JA, Beigel JH, Paolino KM, Voell J, Castellano AR, Hu Z, Muñoz P, Moon JE, Ruck RC, Bennett JW, Twomey PS, Gutiérrez RL, Remich SA, Hack HR, Wisniewski ML, Josleyn MD, Kwilas SA, Van Deusen N, Mbaya OT, Zhou Y, Stanley DA, Jing W, Smith KS, Shi M, Ledgerwood JE, Graham BS, Sullivan NJ, Jagodzinski LL, Peel SA, Alimonti JB, Hooper JW, Silvera PM, Martin BK, Monath TP, Ramsey WJ, Link CJ, Lane HC, Michael NL, Davey RT Jr, Thomas SJ; rVSVΔG-ZEBOV-GP Study Group.

N Engl J Med. 2017 Jan 26;376(4):330-341. doi: 10.1056/NEJMoa1414216. Epub 2015 Apr 1.

4.

VSVΔG/EBOV GP-induced innate protection enhances natural killer cell activity to increase survival in a lethal mouse adapted Ebola virus infection.

Williams KJ, Qiu X, Fernando L, Jones SM, Alimonti JB.

Viral Immunol. 2015 Feb;28(1):51-61. doi: 10.1089/vim.2014.0069.

PMID:
25494457
5.

Immunization with vesicular stomatitis virus vaccine expressing the Ebola glycoprotein provides sustained long-term protection in rodents.

Wong G, Audet J, Fernando L, Fausther-Bovendo H, Alimonti JB, Kobinger GP, Qiu X.

Vaccine. 2014 Sep 29;32(43):5722-9. doi: 10.1016/j.vaccine.2014.08.028. Epub 2014 Aug 27.

PMID:
25173474
6.

Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp.

Qiu X, Wong G, Audet J, Bello A, Fernando L, Alimonti JB, Fausther-Bovendo H, Wei H, Aviles J, Hiatt E, Johnson A, Morton J, Swope K, Bohorov O, Bohorova N, Goodman C, Kim D, Pauly MH, Velasco J, Pettitt J, Olinger GG, Whaley K, Xu B, Strong JE, Zeitlin L, Kobinger GP.

Nature. 2014 Oct 2;514(7520):47-53. doi: 10.1038/nature13777. Epub 2014 Aug 29.

7.

Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb.

Qiu X, Audet J, Wong G, Fernando L, Bello A, Pillet S, Alimonti JB, Kobinger GP.

Sci Rep. 2013 Nov 28;3:3365. doi: 10.1038/srep03365.

8.

mAbs and Ad-vectored IFN-α therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms.

Qiu X, Wong G, Fernando L, Audet J, Bello A, Strong J, Alimonti JB, Kobinger GP.

Sci Transl Med. 2013 Oct 16;5(207):207ra143. doi: 10.1126/scitranslmed.3006605.

9.

Monoclonal antibodies combined with adenovirus-vectored interferon significantly extend the treatment window in Ebola virus-infected guinea pigs.

Qiu X, Wong G, Fernando L, Ennis J, Turner JD, Alimonti JB, Yao X, Kobinger GP.

J Virol. 2013 Jul;87(13):7754-7. doi: 10.1128/JVI.00173-13. Epub 2013 Apr 24.

10.

Successful treatment of ebola virus-infected cynomolgus macaques with monoclonal antibodies.

Qiu X, Audet J, Wong G, Pillet S, Bello A, Cabral T, Strong JE, Plummer F, Corbett CR, Alimonti JB, Kobinger GP.

Sci Transl Med. 2012 Jun 13;4(138):138ra81. doi: 10.1126/scitranslmed.3003876.

11.

Ebola GP-specific monoclonal antibodies protect mice and guinea pigs from lethal Ebola virus infection.

Qiu X, Fernando L, Melito PL, Audet J, Feldmann H, Kobinger G, Alimonti JB, Jones SM.

PLoS Negl Trop Dis. 2012;6(3):e1575. doi: 10.1371/journal.pntd.0001575. Epub 2012 Mar 20.

12.

Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies.

Qiu X, Alimonti JB, Melito PL, Fernando L, Ströher U, Jones SM.

Clin Immunol. 2011 Nov;141(2):218-27. doi: 10.1016/j.clim.2011.08.008. Epub 2011 Aug 31.

PMID:
21925951
13.

Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model.

Bente DA, Alimonti JB, Shieh WJ, Camus G, Ströher U, Zaki S, Jones SM.

J Virol. 2010 Nov;84(21):11089-100. doi: 10.1128/JVI.01383-10. Epub 2010 Aug 25.

14.

Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses.

Qiu X, Fernando L, Alimonti JB, Melito PL, Feldmann F, Dick D, Ströher U, Feldmann H, Jones SM.

PLoS One. 2009;4(5):e5547. doi: 10.1371/journal.pone.0005547. Epub 2009 May 14.

15.

In vitro evaluation of antisense RNA efficacy against filovirus infection, by use of reverse genetics.

Groseth A, Hoenen T, Alimonti JB, Zielecki F, Ebihara H, Theriault S, Ströher U, Becker S, Feldmann H.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S382-9.

PMID:
17940974
16.

In vitro and in vivo characterization of recombinant Ebola viruses expressing enhanced green fluorescent protein.

Ebihara H, Theriault S, Neumann G, Alimonti JB, Geisbert JB, Hensley LE, Groseth A, Jones SM, Geisbert TW, Kawaoka Y, Feldmann H.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S313-22.

PMID:
17940966
17.

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus.

Kobasa D, Jones SM, Shinya K, Kash JC, Copps J, Ebihara H, Hatta Y, Kim JH, Halfmann P, Hatta M, Feldmann F, Alimonti JB, Fernando L, Li Y, Katze MG, Feldmann H, Kawaoka Y.

Nature. 2007 Jan 18;445(7125):319-23.

PMID:
17230189
18.

Characterization of CD8 T-cell responses in HIV-1-exposed seronegative commercial sex workers from Nairobi, Kenya.

Alimonti JB, Kimani J, Matu L, Wachihi C, Kaul R, Plummer FA, Fowke KR.

Immunol Cell Biol. 2006 Oct;84(5):482-5.

PMID:
16942489
19.

IL-7Ralpha expression on CD4+ T lymphocytes decreases with HIV disease progression and inversely correlates with immune activation.

Koesters SA, Alimonti JB, Wachihi C, Matu L, Anzala O, Kimani J, Embree JE, Plummer FA, Fowke KR.

Eur J Immunol. 2006 Feb;36(2):336-44.

20.

CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women.

Alimonti JB, Koesters SA, Kimani J, Matu L, Wachihi C, Plummer FA, Fowke KR.

J Infect Dis. 2005 Jan 1;191(1):20-4. Epub 2004 Dec 1.

PMID:
15592998
21.

Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS.

Alimonti JB, Ball TB, Fowke KR.

J Gen Virol. 2003 Jul;84(Pt 7):1649-61. Review.

PMID:
12810858
22.

Granzyme B induces BID-mediated cytochrome c release and mitochondrial permeability transition.

Alimonti JB, Shi L, Baijal PK, Greenberg AH.

J Biol Chem. 2001 Mar 9;276(10):6974-82. Epub 2000 Dec 12.

23.

Purification of human interleukin-2 using the cellulose-binding domain of a prokaryotic cellulase.

Ong E, Alimonti JB, Greenwood JM, Miller RC Jr, Warren RA, Kilburn DG.

Bioseparation. 1995 Apr;5(2):95-104.

PMID:
7772950

Supplemental Content

Loading ...
Support Center